105 related articles for article (PubMed ID: 1768784)
1. The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinum-induced anemia in golden Syrian hamsters.
Gebbia V; Palmeri S; Valenza R; Rausa L; Citarrella P
In Vivo; 1991; 5(2):149-52. PubMed ID: 1768784
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo.
Clibon U; Bonewald L; Caro J; Roodman GD
Exp Hematol; 1990 Jun; 18(5):438-41. PubMed ID: 2338132
[TBL] [Abstract][Full Text] [Related]
5. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells.
Jaar B; Baillou C; Viron B; Michel C; Mignon F; Najman A
Nephrol Dial Transplant; 1993; 8(7):614-20. PubMed ID: 8396745
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow failure following severe injury in humans.
Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
11. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
12. [In vitro effects of high titers of recombinant human erythropoietin on the bone marrow erythroid progenitors in patients with aplastic anemia].
Aoki I; Chikazawa H; Higashi K; Ishikawa K
Rinsho Ketsueki; 1989 Apr; 30(4):437-42. PubMed ID: 2769966
[TBL] [Abstract][Full Text] [Related]
13. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D
Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin treatment of anemia associated with multiple myeloma.
Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
[TBL] [Abstract][Full Text] [Related]
15. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
17. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
19. Effects of an aplastic anemia urinary extract on mouse erythroid progenitor cells in vivo.
Kamamoto T; Kuriya S; Murphy MJ
Exp Hematol; 1988 May; 16(4):268-73. PubMed ID: 3360064
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
